Search research articles
Contact Us
Filters
Showing results (31-40 of 62) with videos related to
Page
of 7
Sort By:
Journal of Cancer Policy
|
September 7, 2024
Emergency and non-emergency routes to cancer diagnoses in 2020 and 2021: A Population-based study of 154,863 patients
Calum Purdie, Gavin R C Clark, David A Cameron, et al.
European Urology Open Science
|
July 13, 2023
Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non-muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial
Ge Yu, Stephen Rice, Rakesh Heer, et al.
BJU International
|
November 3, 2011
Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking
Paramananthan Mariappan, Steven M Finney, Elizabeth Head, et al.
BJUI Compass
|
June 30, 2026
State of the nation: Understanding the current NHS treatment pathway to identify opportunities to advance future care of patients with high-risk non-muscle invasive bladder cancer in the UK (SPAN-UK)
Jonathan Aning, James W F Catto, Rebecca Martin, et al.
BJU International
|
January 15, 2021
What influences adherence to guidance for postoperative instillation of intravesical chemotherapy to patients with bladder cancer?
Jennifer Dunsmore, Eilidh Duncan, Paramananthan Mariappan, et al.
European Urology
|
July 9, 2014
Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations
J Alfred Witjes, Marek Babjuk, Paolo Gontero, et al.
Investigative and Clinical Urology
|
November 3, 2025
Evaluating diagnostic performance of urinary biomarkers in the surveillance of non-muscle invasive bladder carcinoma: A systematic review
Reena Prhiya Ramasamy, Chu Ann Chai, Angelo Cormio, et al.
European Urology
|
July 22, 2020
Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme
Paramananthan Mariappan, Allan Johnston, Luisa Padovani, et al.
BJU International
|
January 21, 2023
Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real-world findings from NHS England between 2013 and 2019
James W F Catto, Olena Mandrik, Lewis A Quayle, et al.
European Urology
|
August 23, 2022
Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial
Wei Shen Tan, Aaron Prendergast, Charlotte Ackerman, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 62) with videos related to
Sort By:
Page
of 7
Journal of Cancer Policy
|
September 7, 2024
Emergency and non-emergency routes to cancer diagnoses in 2020 and 2021: A Population-based study of 154,863 patients
Calum Purdie, Gavin R C Clark, David A Cameron, et al.
European Urology Open Science
|
July 13, 2023
Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non-muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial
Ge Yu, Stephen Rice, Rakesh Heer, et al.
BJU International
|
November 3, 2011
Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking
Paramananthan Mariappan, Steven M Finney, Elizabeth Head, et al.
BJUI Compass
|
June 30, 2026
State of the nation: Understanding the current NHS treatment pathway to identify opportunities to advance future care of patients with high-risk non-muscle invasive bladder cancer in the UK (SPAN-UK)
Jonathan Aning, James W F Catto, Rebecca Martin, et al.
BJU International
|
January 15, 2021
What influences adherence to guidance for postoperative instillation of intravesical chemotherapy to patients with bladder cancer?
Jennifer Dunsmore, Eilidh Duncan, Paramananthan Mariappan, et al.
European Urology
|
July 9, 2014
Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations
J Alfred Witjes, Marek Babjuk, Paolo Gontero, et al.
Investigative and Clinical Urology
|
November 3, 2025
Evaluating diagnostic performance of urinary biomarkers in the surveillance of non-muscle invasive bladder carcinoma: A systematic review
Reena Prhiya Ramasamy, Chu Ann Chai, Angelo Cormio, et al.
European Urology
|
July 22, 2020
Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme
Paramananthan Mariappan, Allan Johnston, Luisa Padovani, et al.
BJU International
|
January 21, 2023
Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real-world findings from NHS England between 2013 and 2019
James W F Catto, Olena Mandrik, Lewis A Quayle, et al.
European Urology
|
August 23, 2022
Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial
Wei Shen Tan, Aaron Prendergast, Charlotte Ackerman, et al.
Page
of 7